Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Beglinger

Showing results (61-70 of 182) with videos related to

Pageof 19
Sort By:
Inflammatory Intestinal Diseases|July 19, 2018
Low Discontinuation Rate of Infliximab Treatment in Steroid-Dependent/Refractory Crohn's Disease PatientsTanay Kaymak, Federico Moriconi, Jan H Niess, et al.
The Journal of Allergy and Clinical Immunology|August 6, 2008
Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitisAlex Straumann, Christian Bussmann, Sébastien Conus, et al.
Digestion|April 15, 2009
Serum protein electrophoresis: an underused but very useful testStephan R Vavricka, Emanuel Burri, Christoph Beglinger, et al.
Gastrointestinal Endoscopy|April 24, 2003
Risk stratification and safe administration of propofol by registered nurses supervised by the gastroenterologist: a prospective observational study of more than 2000 casesLudwig T Heuss, Patrizia Schnieper, Juergen Drewe, et al.
The American Journal of Gastroenterology|August 9, 2003
Safety of propofol for conscious sedation during endoscopic procedures in high-risk patients-a prospective, controlled studyLudwig T Heuss, Patrizia Schnieper, Juergen Drewe, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 24, 2004
Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in menJean-Pierre Gutzwiller, Lukas Degen, Daniel Matzinger, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 27, 2010
Mechanisms of gastric emptying disturbances in chronic and acute inflammation of the distal gastrointestinal tractJutta Keller, Christoph Beglinger, Jens Juul Holst, et al.
Physiology & Behavior|May 8, 2009
CCK, ghrelin, and PYY responses in individuals with binge eating disorder before and after a cognitive behavioral treatment (CBT)Simone Munsch, Esther Biedert, Andrea H Meyer, et al.
The American Journal of Clinical Nutrition|August 20, 2010
Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjectsRobert E Steinert, Birk Poller, M Cristina Castelli, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Monitoring inflammatory bowel disease activity: clinical activity is judged to be more relevant than endoscopic severity or biomarkersAlain M Schoepfer, Stephan Vavricka, Nadine Zahnd-Straumann, et al.
Pageof 19

Showing results (61-70 of 182) with videos related to

Sort By:
Pageof 19
Inflammatory Intestinal Diseases|July 19, 2018
Low Discontinuation Rate of Infliximab Treatment in Steroid-Dependent/Refractory Crohn's Disease PatientsTanay Kaymak, Federico Moriconi, Jan H Niess, et al.
The Journal of Allergy and Clinical Immunology|August 6, 2008
Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitisAlex Straumann, Christian Bussmann, Sébastien Conus, et al.
Digestion|April 15, 2009
Serum protein electrophoresis: an underused but very useful testStephan R Vavricka, Emanuel Burri, Christoph Beglinger, et al.
Gastrointestinal Endoscopy|April 24, 2003
Risk stratification and safe administration of propofol by registered nurses supervised by the gastroenterologist: a prospective observational study of more than 2000 casesLudwig T Heuss, Patrizia Schnieper, Juergen Drewe, et al.
The American Journal of Gastroenterology|August 9, 2003
Safety of propofol for conscious sedation during endoscopic procedures in high-risk patients-a prospective, controlled studyLudwig T Heuss, Patrizia Schnieper, Juergen Drewe, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 24, 2004
Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in menJean-Pierre Gutzwiller, Lukas Degen, Daniel Matzinger, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 27, 2010
Mechanisms of gastric emptying disturbances in chronic and acute inflammation of the distal gastrointestinal tractJutta Keller, Christoph Beglinger, Jens Juul Holst, et al.
Physiology & Behavior|May 8, 2009
CCK, ghrelin, and PYY responses in individuals with binge eating disorder before and after a cognitive behavioral treatment (CBT)Simone Munsch, Esther Biedert, Andrea H Meyer, et al.
The American Journal of Clinical Nutrition|August 20, 2010
Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjectsRobert E Steinert, Birk Poller, M Cristina Castelli, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Monitoring inflammatory bowel disease activity: clinical activity is judged to be more relevant than endoscopic severity or biomarkersAlain M Schoepfer, Stephan Vavricka, Nadine Zahnd-Straumann, et al.
Pageof 19